Andean nations prefer generics, says study
This article was originally published in Scrip
The availability of branded medicines is low across several Andean countries, according to a report from Health Action International's Latin American office. The study looked at the availability of 42 branded medicines in 42 private and 34 state-owned pharmacies in Bolivia, Colombia, Peru, Venezuela and Ecuador.
You may also be interested in...
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.